BiotechTube
Home/Roar Biomedical/Marie Dagata
MD

Marie Dagata

President

Roar Biomedical

Therapeutic Areas

CardiovascularMetabolic Disease

Roar Biomedical Pipeline

DrugIndicationPhase
CETP Activity AssaysCardiovascular Disease (Pharmacodynamic Biomarker)Commercial
LCAT Activity AssaysCardiovascular/Metabolic Disease (Pharmacodynamic Biomarker)Commercial
Co-branding & DistributionResearch ToolsCommercial

Leadership Team at Roar Biomedical

RW
Robert W. Brocia
Chief Executive Officer
View full Roar Biomedical profile